Hot Topics of Medical Affairs
a partnership driving healthcare innovation

Editorial: Public-Private Partnerships as Drivers of Innovation in Healthcare

This article was originally published on Frontiers in Medicine. Authors: Remco L.A. de Vrueh, Jon S. B. de Vlieger, and Daan J. A. Crommelin Editorial on the Research TopicPublic-Private Partnerships as drivers of innovation in healthcare The format: from bilateral to multilateral Around the turn of the century, a rather simple classification of public-private-partnerships (PPPs) […]

patient involvement in translational medicine

Improving the Translational Medicine Process: Moving Patients From “End-Users” to “Engaged Collaborators”

This article was originally published on Frontiers in Medicine. Authors: Manuela Battaglia1,  Pat Furlong2, Nico Martinus Wulffraat3, and Felicitas Bellutti Enders4 1Diabetes Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy 2Parent Project Muscular Dystrophy, Hackensack, NJ, United States 3Department of Pediatric Immunology, Wilhelmina Children’s Hospital, University Medical Centre Utrecht, Utrecht, Netherlands 4Allergy Unit, Department […]

Medical Affairs Books

International Perception of Competence, Education, and Training Needs Among Biomedical Professionals Involved in Medicines Development

The below excerpt is from an article originally published on the Frontiers in Pharmacology website. To check out the full article click here. The development of new medicines today, requires a multi-professional workforce, both in industry and the clinical research arena. Pharmaceutical physicians (PPs) and medicines development scientists (MDS) need a certain level of competence, […]

Research and development of new medications

R&D Costs & Drug Pricing

R&D Costs & Drug Pricing An article from Kenneth Kaitin, PhD, Professor and Director at Tufts Center for the Study of Drug Development. This article was originally published by Tufts CSDD Insider. Earlier this week, I was interviewed by a National Public Radio affiliate for a segment to be aired in the coming days on […]

Sanofi CEO Olivier Brandicourt Becomes PhRMA Board Chairman

This article excerpt was originally published on the PhRMA website. On January 31st, 2019, the Pharmaceutical Research and Manufacturers of America (PhRMA) elected three new officers to its board of directors. Olivier Brandicourt, CEO, Sanofi, became chairman of the PhRMA board of directors. Giovanni Caforio, M.D., chairman of the Board and CEO, Bristol-Myers Squibb Company […]